Following a series of votes by Conservative MPs, Foreign Secretary Jeremy Hunt MP and Boris Johnson MP are through to the final vote that will decide who will become party leader and Prime Minister. All Conservative party members will cast their vote and the results are expected on 23 July, when Theresa May will formally stand down as Prime Minister.

While we understand that neither candidate has a strong interest in medical research, both are familiar with some of the sector’s priority areas. In 2014, Johnson oversaw the launch of MedCity and he has also previously trumpeted the UK’s cell therapies sector as an area of strength. He has argued that greater regulatory freedom post-Brexit could beneficial. Jeremy Hunt sat on the Life Sciences Council during his tenure as Health & Social Care Secretary and has publicly called for regulatory alignment between the MHRA and EMA post-Brexit.

Back to e-newsletter